JP2019528247A5 - - Google Patents

Download PDF

Info

Publication number
JP2019528247A5
JP2019528247A5 JP2019501619A JP2019501619A JP2019528247A5 JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5 JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019501619 A JP2019501619 A JP 2019501619A JP 2019528247 A5 JP2019528247 A5 JP 2019528247A5
Authority
JP
Japan
Prior art keywords
methylquinoxalin
methoxy
thiazol
oxy
carbamate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019501619A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019528247A (ja
JP7058256B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/041878 external-priority patent/WO2018013774A1/en
Publication of JP2019528247A publication Critical patent/JP2019528247A/ja
Publication of JP2019528247A5 publication Critical patent/JP2019528247A5/ja
Application granted granted Critical
Publication of JP7058256B2 publication Critical patent/JP7058256B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019501619A 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物 Active JP7058256B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662362113P 2016-07-14 2016-07-14
US62/362,113 2016-07-14
PCT/US2017/041878 WO2018013774A1 (en) 2016-07-14 2017-07-13 Bicyclic heteroaryl substituted compounds

Publications (3)

Publication Number Publication Date
JP2019528247A JP2019528247A (ja) 2019-10-10
JP2019528247A5 true JP2019528247A5 (enExample) 2020-08-13
JP7058256B2 JP7058256B2 (ja) 2022-04-21

Family

ID=59384258

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019501619A Active JP7058256B2 (ja) 2016-07-14 2017-07-13 二環式ヘテロアリール置換化合物

Country Status (7)

Country Link
US (2) US20190292176A1 (enExample)
EP (1) EP3484878B1 (enExample)
JP (1) JP7058256B2 (enExample)
KR (1) KR102460385B1 (enExample)
CN (1) CN109689647B (enExample)
ES (1) ES2823180T3 (enExample)
WO (1) WO2018013774A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109689664B (zh) * 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物
CN109689642B (zh) 2016-07-14 2022-04-12 百时美施贵宝公司 经单环杂芳基取代的化合物
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
CN109836360B (zh) * 2019-03-19 2021-08-13 南京恩泰医药科技有限公司 一种甲苯磺酸依度沙班中间体的制备方法及中间体化合物
CN113024475B (zh) * 2019-12-25 2022-08-09 宁夏大学 一种喹喔啉酮类化合物的合成方法
CN111440146B (zh) * 2020-05-15 2022-10-21 中国药科大学 一种具有par4拮抗活性的苯并三嗪类化合物及其应用
JP7753950B2 (ja) * 2022-03-30 2025-10-15 三菱ケミカル株式会社 環状亜硫酸エステルの製造方法
EP4561983A1 (en) 2022-07-28 2025-06-04 Bayer Aktiengesellschaft Process for preparation of 2-chloro-3-fluoro-4-alkoxy-anilines and 2-fluoro-3-chlorophenol
WO2024131948A1 (zh) * 2022-12-22 2024-06-27 人福医药集团股份公司 制备p2x3抑制剂的方法
CN115925588A (zh) * 2022-12-26 2023-04-07 诚达药业股份有限公司 一种脂肪族亚磺酸钠盐的制备方法
AR131541A1 (es) 2023-01-07 2025-04-09 Syngenta Crop Protection Ag Compuestos de carboxamida novedosos
WO2025032129A1 (en) 2023-08-08 2025-02-13 Syngenta Crop Protection Ag Novel aminoindane and aminotetraline compounds
US11986461B1 (en) 2023-08-24 2024-05-21 King Faisal University 3-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-ol as an antitumor and antimicrobial compound
US11976055B1 (en) 2023-08-24 2024-05-07 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl)pyridin-3-ol as an antitumor and antimicrobial compound
US11964959B1 (en) 2023-09-05 2024-04-23 King Faisal University 3-(4,5-Diphenyl-2-(pyridin-3-yl)-1H-imidazol-1-yl)-N,N-dimethylpopan-1-amine as an antimicrobial compound
WO2025109114A1 (en) 2023-11-24 2025-05-30 Syngenta Crop Protection Ag Novel carboxamide compounds
US11952361B1 (en) 2023-12-26 2024-04-09 King Faisal University 2-(1-(3-(dimethylamino)propyl)-4,5-diphenyl-1H-imidazol-2-yl) pyridin-3-ol as an antitumor and antimicrobial compound
PY2501648A (es) 2024-01-12 2025-10-31 Syngenta Crop Protection Ag Nuevos compuestos de carboxamida
WO2025149637A1 (en) 2024-01-12 2025-07-17 Syngenta Crop Protection Ag Novel carboxamide compounds
WO2026008750A1 (en) 2024-07-05 2026-01-08 Syngenta Crop Protection Ag Novel carboxamide compounds

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1164459A (en) * 1980-11-11 1984-03-27 Yung-Hsiung Yang Process for preparing (imidazo¬1,2-a|pyridine- 2-yl)-carbostyril or -3,4-dihydrocarbostyryl derivatives
YU136287A (en) * 1986-07-25 1990-06-30 Boehringer Kg Process for preparing new 1,4 benzodiazepines
TW279162B (enExample) * 1991-09-26 1996-06-21 Mitsubishi Chem Corp
JP2928079B2 (ja) 1994-02-14 1999-07-28 永信薬品工業股▲ふん▼有限公司 1−(置換ベンジル)−3−(置換アリール)縮合ピラゾール類、その製造法及びその用途
US6166041A (en) 1995-10-11 2000-12-26 Euro-Celtique, S.A. 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma
DE69723863T2 (de) * 1996-11-06 2004-04-15 Darwin Discovery Ltd., Slough Chinoline und deren therapeutische verwendung
US6313126B1 (en) * 1999-01-07 2001-11-06 American Home Products Corp Arylpiperazinyl-cyclohexyl indole derivatives for the treatment of depression
US6387942B2 (en) 2000-06-19 2002-05-14 Yung Shin Pharmaceutical Ind. Co. Ltd Method of treating disorders related to protease-activated receptors-induced cell activation
EP1348701A1 (en) 2002-03-28 2003-10-01 Warner-Lambert Company LLC (2,4-disubstituted-thiazol-5-yl) amine compounds as PDE7 inhibitors
JP2007501189A (ja) 2003-08-01 2007-01-25 ジェネラブス テクノロジーズ,インコーポレイテッド フラビウイルス科に対する二環式イミダゾール誘導体
WO2005113522A1 (en) 2004-05-07 2005-12-01 Janssen Pharmaceutica, N.V. Azole carboxamide inhibitors of bacterial type iii protein secretion systems
US20090054417A1 (en) 2004-07-28 2009-02-26 Irm Llc Compounds and compositions as modulators of steroid hormone nuclear receptors
CN101103026A (zh) 2005-01-14 2008-01-09 健亚生物科技公司 用于治疗病毒感染的吲哚衍生物
US20080015193A1 (en) 2006-06-20 2008-01-17 Mendoza Jose S Certain azoles exhibiting ATP-utilizing enzyme inhibitory activity, compositions, and uses thereof
CN101479249B (zh) 2006-06-29 2012-10-10 霍夫曼-拉罗奇有限公司 苯并咪唑衍生物、其制备方法、它们作为fxr激动剂的用途及含有它们的药物制剂
WO2008073451A2 (en) 2006-12-11 2008-06-19 Sirtris Pharmaceuticals, Inc. Benzoimidazole derivatives as sirtuin (sir) modulating compounds
EA201000915A1 (ru) 2007-11-30 2011-02-28 ГЛЭКСОСМИТКЛАЙН ЭлЭлСи Ингибиторы пролилгидроксилазы
ES2586459T3 (es) 2008-05-01 2016-10-14 Glaxosmithkline Llc Quinolinas y análogos relacionados como moduladores de sirtuina
ES2554513T3 (es) 2008-05-23 2015-12-21 Novartis Ag Derivados de quinolinas y quinoxalinas como inhibidores de la proteína tirosina quinasa
AU2009274023A1 (en) 2008-07-23 2010-01-28 Vertex Pharmaceuticals Incorporated Tri-cyclic pyrazolopyridine kinase inhibitors
TW201018682A (en) * 2008-09-25 2010-05-16 Kyorin Seiyaku Kk Heterocyclic biaryl derivative, and pde inhibitor comprising same as active ingredient
US20130072473A1 (en) 2011-05-09 2013-03-21 Proteostasis Therapeutics, Inc. Compounds for treating protein folding disorders
TW201348226A (zh) 2012-02-28 2013-12-01 Amgen Inc 作為pim抑制劑之醯胺
SI2841437T1 (sl) 2012-04-26 2017-09-29 Bristol-Myers Squibb Company Derivati imidazotiadiazola in imidazopirazina kot proteazno aktivirani receptor 4 (PAR4) inhibitorji za zdravljenje agregacije trombocitov
EP2855489B1 (en) 2012-04-26 2017-01-04 Bristol-Myers Squibb Company Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
SG11201406759YA (en) 2012-04-26 2014-11-27 Bristol Myers Squibb Co Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
US9598419B1 (en) 2014-06-24 2017-03-21 Universite De Montreal Imidazotriazine and imidazodiazine compounds
US9617279B1 (en) 2014-06-24 2017-04-11 Bristol-Myers Squibb Company Imidazooxadiazole compounds
EP3262052A1 (en) 2015-02-26 2018-01-03 Bristol-Myers Squibb Company Benzothiazole and benzothiophne compounds
WO2016134450A1 (en) 2015-02-26 2016-09-01 Université de Montréal Imidazopyridazine and imidazothiadiazole compounds
CA2979302A1 (en) * 2015-05-13 2016-11-17 Selvita S.A. Substituted quinoxaline derivatives
CN108137514A (zh) 2015-07-30 2018-06-08 百时美施贵宝公司 芳基取代的二环杂芳基化合物
KR102494647B1 (ko) 2016-07-14 2023-01-31 브리스톨-마이어스 스큅 컴퍼니 비시클릭 헤테로아릴 치환된 화합물
CN109689642B (zh) 2016-07-14 2022-04-12 百时美施贵宝公司 经单环杂芳基取代的化合物
CN109689664B (zh) 2016-07-14 2022-04-15 百时美施贵宝公司 作为par4抑制剂的三环杂芳基取代的喹啉和氮杂喹啉化合物

Similar Documents

Publication Publication Date Title
JP2019528247A5 (enExample)
JP7126541B2 (ja) ハンチントンタンパク質のイメージング用プローブ
CN104583218B (zh) 作为蛋白酶活化受体4(par4)抑制剂用于治疗血小板聚集的咪唑并噻二唑和咪唑并吡嗪的衍生物
JP7440101B2 (ja) キナーゼ阻害剤としてのヘテロ環式化合物、ヘテロ環式化合物を含む組成物、及びそれらを使用する方法
ES2823180T3 (es) Compuestos bicíclicos sustituidos con heteroarilo
CN111032656B (zh) 杂环化合物激酶抑制剂及其药物组合物和应用
JP2020527560A5 (enExample)
RU2010134900A (ru) 5-фторпиримидиновые производные в качестве фунгицидов
JP2016500073A5 (enExample)
JP2017526622A (ja) 3−アミノ−1,5,6,7−テトラヒドロ−4h−インドール−4−オン類
AU2014347027A1 (en) GSK -3 inhibitors
JP2022505707A5 (enExample)
CA2897469A1 (en) Pyridine derivatives as muscarinic m1 receptor positive allosteric modulators
JP2019524732A5 (enExample)
CN104125947A (zh) 杂环脲化合物
KR102390234B1 (ko) 트리시클릭 피페리딘 화합물
WO2012064269A1 (en) COMPOUNDS AND THEIR USE FOR TREATMENT OF Αβ-RELATED DISEASES
WO2009128661A2 (ko) 신규 벤조옥사진 벤즈이미다졸 유도체, 이를 포함하는 약학 조성물 및 이의 용도
AU2015212495A1 (en) Antibacterial combinations comprising polymyxin
EP4612134A1 (en) Diaryl diazole and diaryl triazole derivatives for use in treating a disease associated with kcnk13 activity
WO2026035776A1 (en) Pi3k-alpha binding compounds and uses thereof
RU2025114402A (ru) Получение производных пиразолопиридина и триазолопиридина в качестве новых ингибиторов диацилглицерид о-ацилтрансферазы 2